Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s10549-010-1085-7.

Title:
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo | Breast Cancer Research and Treatment
Description:
Thus far the clinical benefits seen in breast cancer patients treated with drugs targeting the vascular endothelial growth factor (VEGF) pathway are only modest. Consequently, additional antiangiogenic approaches for treatment of breast cancer need to be investigated. Thrombospondin-2 (TSP-2) has been shown to inhibit tumor growth and angiogenesis with a greater potency than the related molecule TSP-1. The systemic effects of TSP-2 on tumor metastasis and the underlying molecular mechanisms of the antiangiogenic activity of TSP-2 have remained poorly understood. We generated a recombinant fusion protein consisting of the N-terminal region of TSP-2 and the IgG-Fc1 fragment (N-TSP2-Fc) and could demonstrate that the antiangiogenic activity of N-TSP2-Fc is dependent on the CD36 receptor. We found that N-TSP2-Fc inhibited VEGF-induced tube formation of human dermal microvascular endothelial cells (HDMEC) on matrigel in vitro and that concurrent incubation of anti-CD36 antibody with N-TSP2-Fc resulted in tube formation that was comparable to untreated control. N-TSP2-Fc potently induced apoptosis of HDMEC in vitro in a CD36-dependent manner. Moreover, we could demonstrate a CD36 receptor-mediated loss of mitochondrial membrane potential and activation of caspase-3 in HDMEC in vitro. Daily intraperitoneal injections of N-TSP2-Fc resulted in a significant inhibition of the growth of human MDA-MB-435 and MDA-MB-231 tumor cells grown in the mammary gland of immunodeficient nude mice and in reduced tumor vascularization. Finally, increased serum concentrations of N-TSP2-Fc significantly inhibited regional metastasis to lymph nodes and distant metastasis to lung as shown by quantitative real-time alu PCR. These results identify N-TSP2-Fc as a potent systemic inhibitor of tumor metastasis and provide strong evidence for an important role of the CD36 receptor in mediating the antiangiogenic activity of TSP-2.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💾}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

ntspfc, tumor, cell, cancer, google, scholar, tsp, pubmed, breast, article, cas, mdamb, growth, human, metastasis, cells, hdmec, mice, treatment, thrombospondin, fig, angiogenesis, antiangiogenic, lymph, dna, endothelial, control, activity, antibody, lung, tissue, tumors, ÎŒgml, recombinant, significant, inhibition, node, compared, activation, apoptosis, tube, alu, systemic, potential, concentration, pbs, injection, vivo, formation, caspase,

Topics {✒}

quencher dye 6-carboxy-tetramethyl-rhodamin results identify n-tsp2-fc gĂŒnter emons & thomas hawighorst n-tsp2-fc-coated wells n-tsp2-fc significantly reduced n-tsp2-fc rapidly decreased n-tsp2-fc-treated mice n-tsp2-fc inhibits reporter dye 6-carboxy-fluorescein n-tsp2-fc-treated tumors n-tsp2-fc inhibited transforming growth factor-beta human mda-mb-435 cells mda-mb-435 cell line mda-mb-435 breast cancer vegf-induced tube formation transforming growth factor-ÎČ mda-mb-231 breast carcinomas computer-assisted image analysis mda-mb-435 tumor cells n-tsp2-fc results n-tsp2-fc contained n-tsp2-fc failed recombinant n-tsp2-fc mda-mb-435 tumors grown real-time pcr assay basal-type breast cancers mda-mb-435 tumor growth sided unpaired t-test student–newman–keuls’ test n-terminal recombinant fragment n-tsp2-fc resulted quantitative real-time pcr n-terminal globular domain ncr nu/nu mice n-terminal globular region cd31-stained blood vessels becton-dickinson immunocytometry systems georg-august-university göttingen multi-detection microplate reader mda-mb-435 tumors reached anti-angiogenic thrombospondin-2 variant urokinase-type plasminogen activator human 293-ebna cells article download pdf tumor-bearing mice treated untreated tumor-bearing mice ïżœïżœct = ct alu  − ct18srrna recombinant heparin-binding domain xenotransplanted mda-mb-435

Questions {❓}

  • Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?
  • Hollestelle A, Schutte M (2009) Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma?

Schema {đŸ—ș}

WebPage:
      mainEntity:
         headline:CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
         description:Thus far the clinical benefits seen in breast cancer patients treated with drugs targeting the vascular endothelial growth factor (VEGF) pathway are only modest. Consequently, additional antiangiogenic approaches for treatment of breast cancer need to be investigated. Thrombospondin-2 (TSP-2) has been shown to inhibit tumor growth and angiogenesis with a greater potency than the related molecule TSP-1. The systemic effects of TSP-2 on tumor metastasis and the underlying molecular mechanisms of the antiangiogenic activity of TSP-2 have remained poorly understood. We generated a recombinant fusion protein consisting of the N-terminal region of TSP-2 and the IgG-Fc1 fragment (N-TSP2-Fc) and could demonstrate that the antiangiogenic activity of N-TSP2-Fc is dependent on the CD36 receptor. We found that N-TSP2-Fc inhibited VEGF-induced tube formation of human dermal microvascular endothelial cells (HDMEC) on matrigel in vitro and that concurrent incubation of anti-CD36 antibody with N-TSP2-Fc resulted in tube formation that was comparable to untreated control. N-TSP2-Fc potently induced apoptosis of HDMEC in vitro in a CD36-dependent manner. Moreover, we could demonstrate a CD36 receptor-mediated loss of mitochondrial membrane potential and activation of caspase-3 in HDMEC in vitro. Daily intraperitoneal injections of N-TSP2-Fc resulted in a significant inhibition of the growth of human MDA-MB-435 and MDA-MB-231 tumor cells grown in the mammary gland of immunodeficient nude mice and in reduced tumor vascularization. Finally, increased serum concentrations of N-TSP2-Fc significantly inhibited regional metastasis to lymph nodes and distant metastasis to lung as shown by quantitative real-time alu PCR. These results identify N-TSP2-Fc as a potent systemic inhibitor of tumor metastasis and provide strong evidence for an important role of the CD36 receptor in mediating the antiangiogenic activity of TSP-2.
         datePublished:2010-08-17T00:00:00Z
         dateModified:2010-08-17T00:00:00Z
         pageStart:337
         pageEnd:346
         license:https://creativecommons.org/licenses/by-nc/2.0/
         sameAs:https://doi.org/10.1007/s10549-010-1085-7
         keywords:
            Breast cancer
            Thrombospondin-2
            CD36
            Metastasis
            Angiogenesis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig4_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:128
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Manuel Koch
               affiliation:
                     name:University of Cologne
                     address:
                        name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fadi Hussein
               affiliation:
                     name:University Medical Center Göttingen, Georg-August-University Göttingen
                     address:
                        name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andreas Woeste
               affiliation:
                     name:University of Cologne
                     address:
                        name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carsten GrĂŒndker
               affiliation:
                     name:University Medical Center Göttingen, Georg-August-University Göttingen
                     address:
                        name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karl Frontzek
               affiliation:
                     name:University Medical Center Göttingen, Georg-August-University Göttingen
                     address:
                        name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:GĂŒnter Emons
               affiliation:
                     name:University Medical Center Göttingen, Georg-August-University Göttingen
                     address:
                        name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Hawighorst
               affiliation:
                     name:University Medical Center Göttingen, Georg-August-University Göttingen
                     address:
                        name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
      description:Thus far the clinical benefits seen in breast cancer patients treated with drugs targeting the vascular endothelial growth factor (VEGF) pathway are only modest. Consequently, additional antiangiogenic approaches for treatment of breast cancer need to be investigated. Thrombospondin-2 (TSP-2) has been shown to inhibit tumor growth and angiogenesis with a greater potency than the related molecule TSP-1. The systemic effects of TSP-2 on tumor metastasis and the underlying molecular mechanisms of the antiangiogenic activity of TSP-2 have remained poorly understood. We generated a recombinant fusion protein consisting of the N-terminal region of TSP-2 and the IgG-Fc1 fragment (N-TSP2-Fc) and could demonstrate that the antiangiogenic activity of N-TSP2-Fc is dependent on the CD36 receptor. We found that N-TSP2-Fc inhibited VEGF-induced tube formation of human dermal microvascular endothelial cells (HDMEC) on matrigel in vitro and that concurrent incubation of anti-CD36 antibody with N-TSP2-Fc resulted in tube formation that was comparable to untreated control. N-TSP2-Fc potently induced apoptosis of HDMEC in vitro in a CD36-dependent manner. Moreover, we could demonstrate a CD36 receptor-mediated loss of mitochondrial membrane potential and activation of caspase-3 in HDMEC in vitro. Daily intraperitoneal injections of N-TSP2-Fc resulted in a significant inhibition of the growth of human MDA-MB-435 and MDA-MB-231 tumor cells grown in the mammary gland of immunodeficient nude mice and in reduced tumor vascularization. Finally, increased serum concentrations of N-TSP2-Fc significantly inhibited regional metastasis to lymph nodes and distant metastasis to lung as shown by quantitative real-time alu PCR. These results identify N-TSP2-Fc as a potent systemic inhibitor of tumor metastasis and provide strong evidence for an important role of the CD36 receptor in mediating the antiangiogenic activity of TSP-2.
      datePublished:2010-08-17T00:00:00Z
      dateModified:2010-08-17T00:00:00Z
      pageStart:337
      pageEnd:346
      license:https://creativecommons.org/licenses/by-nc/2.0/
      sameAs:https://doi.org/10.1007/s10549-010-1085-7
      keywords:
         Breast cancer
         Thrombospondin-2
         CD36
         Metastasis
         Angiogenesis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-010-1085-7/MediaObjects/10549_2010_1085_Fig4_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:128
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Manuel Koch
            affiliation:
                  name:University of Cologne
                  address:
                     name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fadi Hussein
            affiliation:
                  name:University Medical Center Göttingen, Georg-August-University Göttingen
                  address:
                     name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andreas Woeste
            affiliation:
                  name:University of Cologne
                  address:
                     name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carsten GrĂŒndker
            affiliation:
                  name:University Medical Center Göttingen, Georg-August-University Göttingen
                  address:
                     name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karl Frontzek
            affiliation:
                  name:University Medical Center Göttingen, Georg-August-University Göttingen
                  address:
                     name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:GĂŒnter Emons
            affiliation:
                  name:University Medical Center Göttingen, Georg-August-University Göttingen
                  address:
                     name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Hawighorst
            affiliation:
                  name:University Medical Center Göttingen, Georg-August-University Göttingen
                  address:
                     name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:128
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Cologne
      address:
         name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University Medical Center Göttingen, Georg-August-University Göttingen
      address:
         name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
         type:PostalAddress
      name:University Medical Center Göttingen, Georg-August-University Göttingen
      address:
         name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
         type:PostalAddress
      name:University Medical Center Göttingen, Georg-August-University Göttingen
      address:
         name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
         type:PostalAddress
      name:University Medical Center Göttingen, Georg-August-University Göttingen
      address:
         name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
         type:PostalAddress
      name:University Medical Center Göttingen, Georg-August-University Göttingen
      address:
         name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Manuel Koch
      affiliation:
            name:University of Cologne
            address:
               name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:Fadi Hussein
      affiliation:
            name:University Medical Center Göttingen, Georg-August-University Göttingen
            address:
               name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      name:Andreas Woeste
      affiliation:
            name:University of Cologne
            address:
               name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:Carsten GrĂŒndker
      affiliation:
            name:University Medical Center Göttingen, Georg-August-University Göttingen
            address:
               name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      name:Karl Frontzek
      affiliation:
            name:University Medical Center Göttingen, Georg-August-University Göttingen
            address:
               name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      name:GĂŒnter Emons
      affiliation:
            name:University Medical Center Göttingen, Georg-August-University Göttingen
            address:
               name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      name:Thomas Hawighorst
      affiliation:
            name:University Medical Center Göttingen, Georg-August-University Göttingen
            address:
               name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
      name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
      name:Institute for Oral and Musculoskeletal Biology, Department of Dermatology, Center for Biochemistry, Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany
      name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
      name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
      name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany
      name:Department of Gynecology and Obstetrics, University Medical Center Göttingen, Georg-August-University Göttingen, Göttingen, Germany

External Links {🔗}(185)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

5.03s.